谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Efficacy of SHR4640 Combined with Febuxostat for Primary Hyperuricemia: a Multicenter, Randomized, Double-Blind, Phase II Study.

Therapeutic Advances in Musculoskeletal Disease(2022)

引用 10|浏览30
关键词
febuxostat,gout,primary hyperuricemia,SHR4640,URAT-1 inhibitor,XOIs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要